Mixture designs to assess composition–structure–property relationships in SiO2–CaO–ZnO–La2O3–TiO2–MgO–SrO–Na2O glasses: Potential materials for embolization
Authors:
- 3 August 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 28 (3) , 416-433
Abstract
Embolization with micron-sized particulates is widely applied to treat uterine fibroids. The objective of this work was to develop mixture designs to predict materials composition–structure–property relationships for the SiO2–CaO–ZnO–La2O3–TiO2–MgO–SrO–Na2O glass system and compare its fundamental materials properties (density and cytocompatibility), against a state-of-the-art embolic agent (contour polyvinyl alcohol) to assess the potential of these materials for embolization therapies. The glass structures were evaluated using 29Si MAS NMR to identify chemical shift and line width; the particulate densities were determined using helium pycnometry and the cell viabilities were assessed via MTT assay. 29Si MAS NMR results indicated peak maxima for each glass in the range of −82.3 ppm to −89.9 ppm; associated with Q2 to Q3 units in silicate glasses. All experimental embolic compositions showed enhanced in vitro compatibility in comparison to Contour PVA with the exceptions of ORP9 and ORP11 (containing no TiO2). In this study, optimal compositions for cell viability were obtained for the following compositional ranges: 0.095–0.188 mole fraction ZnO; 0.068–0.159 mole fraction La2O3; 0.545–0.562 mole fraction SiO2 and 0.042–0.050 mole fraction TiO2. To ensure ease of producibility in obtaining good melts, a maximum loading of 0.068 mole fraction La2O3 is required. This is confirmed by the desirability approach, for which the only experimental composition (ORP5) of the materials evaluated was presented as an optimum composition; combining high cell viability with ease of production (0.188 mole fraction ZnO; 0.068 mole fraction La2O3; 0.562 mole fraction SiO2 and 0.042 mole fraction TiO2).Keywords
This publication has 35 references indexed in Scilit:
- Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trialAmerican Journal of Obstetrics and Gynecology, 2010
- Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisationJournal of Materials Science: Materials in Medicine, 2010
- What Evidence Should We Demand before Accepting a New Embolic Material for Uterine Artery Embolization?Journal of Vascular and Interventional Radiology, 2009
- Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysisFertility and Sterility, 2009
- Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trialAmerican Journal of Obstetrics and Gynecology, 2007
- Uterine-Artery Embolization versus Surgery for Symptomatic Uterine FibroidsNew England Journal of Medicine, 2007
- Spherical Polyvinyl Alcohol versus Tris-acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomas: Results of a Limited Randomized Comparative StudyJournal of Vascular and Interventional Radiology, 2005
- Uterine Fibroids: Uterine Artery Embolization versus Abdominal Hysterectomy for Treatment—A Prospective, Randomized, and Controlled Clinical TrialRadiology, 2003
- High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidenceAmerican Journal of Obstetrics and Gynecology, 2003
- Arterial embolisation to treat uterine myomataThe Lancet, 1995